| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 11.126 | 0 | 9.865 | 11.149 | 10.826 |
| Total Income - EUR | - | - | - | - | - | 11.126 | 0 | 10.717 | 11.149 | 10.826 |
| Total Expenses - EUR | - | - | - | - | - | 16.271 | 7.837 | 8.983 | 8.880 | 11.175 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -5.145 | -7.837 | 1.735 | 2.269 | -349 |
| Net Profit/Loss - EUR | - | - | - | - | - | -5.256 | -7.837 | 1.627 | 2.170 | -349 |
| Employees | - | - | - | - | - | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Transmeclori S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 4.297 | 3.722 | 0 | 0 | 0 |
| Current Assets | - | - | - | - | - | 935 | 1.124 | 1.882 | 4.045 | 3.374 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 515 | 697 | 1.812 | 1.807 | 1.797 |
| Cash | - | - | - | - | - | 420 | 428 | 70 | 2.238 | 1.577 |
| Shareholders Funds | - | - | - | - | - | -8.124 | -15.781 | -14.202 | -11.989 | -12.271 |
| Social Capital | - | - | - | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | 13.356 | 20.626 | 16.084 | 16.034 | 15.645 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4941 - 4941" | |||||||||
| CAEN Financial Year |
4941
|
|||||||||
Comments - Transmeclori S.r.l.